Type III interferon (IFN-λ) antagonizes the antiviral activity of interferon-α in vitro

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Type III interferons (IFN-λ) are the most recently discovered members of IFN family. Synergism between different IFN types is well established, but for type I and type III IFNs no conclusive evidence has been reported so far. Possible synergism/antagonism between IFN-α and IFN-λ in the inhibition of virus replication (EMCV, WNV lineage 1 and 2, CHIKV and HSV-1), and in the activation of intracellular pathways of IFN response (MxA and 2′-5′ OAS) was evaluated in different cell lines (Vero E6, A549 and Wish cells). The antiviral potency of IFN-λ1 and -I2 was lower than that of IFN-α. When IFN-α and -λ were used together, the Combination Index (CI) for virus inhibition was >1 virtually for all virus/host cell systems, indicating antagonistic effect. Antagonism between IFN-α and -I was also observed for the induction of mRNA for both MxA and 2′-5′OAS. Elucidating the interplay between IFN-α and -λ may help to better understand innate defence mechanisms against viral infections, including the molecular mechanisms underlying the influence of IL-28B polymorphisms in the response to HCV and other viral infections.

Original languageEnglish
Pages (from-to)1001-1009
Number of pages9
JournalJournal of Biological Regulators and Homeostatic Agents
Volume27
Issue number4
Publication statusPublished - Oct 2013

Fingerprint

Interferons
Antiviral Agents
Virus Diseases
Encephalomyocarditis virus
Viruses
In Vitro Techniques
Human Herpesvirus 1
Defense Mechanisms
Virus Replication
Cell Line
Messenger RNA

Keywords

  • Antagonism
  • Antiviral activity
  • Combination index
  • IFN-α
  • IFN-λ
  • Interferon-stimulated genes

ASJC Scopus subject areas

  • Oncology
  • Endocrinology, Diabetes and Metabolism
  • Physiology (medical)
  • Immunology and Allergy
  • Immunology
  • Endocrinology
  • Physiology
  • Cancer Research

Cite this

@article{21d9b34bf55e47afad99845e0fc630be,
title = "Type III interferon (IFN-λ) antagonizes the antiviral activity of interferon-α in vitro",
abstract = "Type III interferons (IFN-λ) are the most recently discovered members of IFN family. Synergism between different IFN types is well established, but for type I and type III IFNs no conclusive evidence has been reported so far. Possible synergism/antagonism between IFN-α and IFN-λ in the inhibition of virus replication (EMCV, WNV lineage 1 and 2, CHIKV and HSV-1), and in the activation of intracellular pathways of IFN response (MxA and 2′-5′ OAS) was evaluated in different cell lines (Vero E6, A549 and Wish cells). The antiviral potency of IFN-λ1 and -I2 was lower than that of IFN-α. When IFN-α and -λ were used together, the Combination Index (CI) for virus inhibition was >1 virtually for all virus/host cell systems, indicating antagonistic effect. Antagonism between IFN-α and -I was also observed for the induction of mRNA for both MxA and 2′-5′OAS. Elucidating the interplay between IFN-α and -λ may help to better understand innate defence mechanisms against viral infections, including the molecular mechanisms underlying the influence of IL-28B polymorphisms in the response to HCV and other viral infections.",
keywords = "Antagonism, Antiviral activity, Combination index, IFN-α, IFN-λ, Interferon-stimulated genes",
author = "L. Bordi and E. Lalle and D. Lapa and C. Caglioti and S. Quartu and Capobianchi, {Maria Rosaria} and C. Castilletti",
year = "2013",
month = "10",
language = "English",
volume = "27",
pages = "1001--1009",
journal = "Journal of Biological Regulators and Homeostatic Agents",
issn = "0393-974X",
publisher = "Biolife s.a.s.",
number = "4",

}

TY - JOUR

T1 - Type III interferon (IFN-λ) antagonizes the antiviral activity of interferon-α in vitro

AU - Bordi, L.

AU - Lalle, E.

AU - Lapa, D.

AU - Caglioti, C.

AU - Quartu, S.

AU - Capobianchi, Maria Rosaria

AU - Castilletti, C.

PY - 2013/10

Y1 - 2013/10

N2 - Type III interferons (IFN-λ) are the most recently discovered members of IFN family. Synergism between different IFN types is well established, but for type I and type III IFNs no conclusive evidence has been reported so far. Possible synergism/antagonism between IFN-α and IFN-λ in the inhibition of virus replication (EMCV, WNV lineage 1 and 2, CHIKV and HSV-1), and in the activation of intracellular pathways of IFN response (MxA and 2′-5′ OAS) was evaluated in different cell lines (Vero E6, A549 and Wish cells). The antiviral potency of IFN-λ1 and -I2 was lower than that of IFN-α. When IFN-α and -λ were used together, the Combination Index (CI) for virus inhibition was >1 virtually for all virus/host cell systems, indicating antagonistic effect. Antagonism between IFN-α and -I was also observed for the induction of mRNA for both MxA and 2′-5′OAS. Elucidating the interplay between IFN-α and -λ may help to better understand innate defence mechanisms against viral infections, including the molecular mechanisms underlying the influence of IL-28B polymorphisms in the response to HCV and other viral infections.

AB - Type III interferons (IFN-λ) are the most recently discovered members of IFN family. Synergism between different IFN types is well established, but for type I and type III IFNs no conclusive evidence has been reported so far. Possible synergism/antagonism between IFN-α and IFN-λ in the inhibition of virus replication (EMCV, WNV lineage 1 and 2, CHIKV and HSV-1), and in the activation of intracellular pathways of IFN response (MxA and 2′-5′ OAS) was evaluated in different cell lines (Vero E6, A549 and Wish cells). The antiviral potency of IFN-λ1 and -I2 was lower than that of IFN-α. When IFN-α and -λ were used together, the Combination Index (CI) for virus inhibition was >1 virtually for all virus/host cell systems, indicating antagonistic effect. Antagonism between IFN-α and -I was also observed for the induction of mRNA for both MxA and 2′-5′OAS. Elucidating the interplay between IFN-α and -λ may help to better understand innate defence mechanisms against viral infections, including the molecular mechanisms underlying the influence of IL-28B polymorphisms in the response to HCV and other viral infections.

KW - Antagonism

KW - Antiviral activity

KW - Combination index

KW - IFN-α

KW - IFN-λ

KW - Interferon-stimulated genes

UR - http://www.scopus.com/inward/record.url?scp=84893261479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893261479&partnerID=8YFLogxK

M3 - Article

C2 - 24382181

AN - SCOPUS:84893261479

VL - 27

SP - 1001

EP - 1009

JO - Journal of Biological Regulators and Homeostatic Agents

JF - Journal of Biological Regulators and Homeostatic Agents

SN - 0393-974X

IS - 4

ER -